keyword
https://read.qxmd.com/read/36837449/impact-of-innovative-treatment-using-biological-drugs-for-the-modulation-of-diffuse-cutaneous-systemic-sclerosis-a-systematic-review
#21
REVIEW
Diego Fernández-Lázaro, María Iglesias-Lázaro, Evelina Garrosa, Saray Rodríguez-García, David Jerves Donoso, Eduardo Gutiérrez-Abejón, Conrado Jorge-Finnigan
Scleroderma or systemic sclerosis (SSc) is an autoimmune disease affecting the connective tissue, characterized by fibrosis of the skin and internal organs. There is currently no curative treatment available, so therapeutic action is aimed at a symptomatic treatment of the affected organs. The development of biotechnology has made it possible to implement certain biological drugs that could represent a window of opportunity to modulate the evolution and symptomatology of scleroderma with greater efficacy and less toxicity than conventional treatments...
January 27, 2023: Medicina
https://read.qxmd.com/read/36825818/rapid-improvement-of-systemic-sclerosis-associated-intestinal-pseudo-obstruction-with-intravenous-immunoglobulin-administration
#22
JOURNAL ARTICLE
Kazuki M Matsuda, Ayumi Yoshizaki, Ai Kuzumi, Satoshi Toyama, Kentaro Awaji, Tomomi Miyake, Shinichi Sato
OBJECTIVES: Systemic sclerosis (SSc) is an autoimmune disease characterized by excessive fibrosis in multiple organs, including the gastrointestinal (GI) tract. GI symptoms of SSc such as intestinal pseudo-obstruction (IPO) are often refractory to conventional intervention and can result in longer in-hospital stay or even increased mortality. We aimed to summarize the insights to date regarding the efficacy of IVIG against GI symptoms of SSc to unveil what we should focus on in future studies...
February 24, 2023: Rheumatology
https://read.qxmd.com/read/36660606/the-clinical-manifestations-and-efficacy-of-different-treatments-used-for-nephrogenic-systemic-fibrosis-a-systematic-review
#23
REVIEW
Shaheer Farooqi, Afshan Mumtaz, Aabiya Arif, Mehwish Butt, Una Kanor, Samuel Memoh, Mohammad Aadil Qamar, Abubakr Yosufi
AIM: Nephrogenic systemic fibrosis (NSF) is a rare disorder that occurs in association majorly with chronic kidney disease (CKD). The lack of collective quantitative data on its clinical manifestations and the different treatment options' efficacy, call the need for our investigation. METHODS: A systematic review was conducted covering a timeline from inception up to July 2022 without any restrictions. Article screening and data extraction were performed independently on PubMed, Google Scholar, ScienceDirect, and Cochrane Library...
2023: International Journal of Nephrology and Renovascular Disease
https://read.qxmd.com/read/36534350/the-role-of-asymmetric-dimethylarginine-in-endothelial-dysfunction-and-abnormal-nitric-oxide-metabolism-in-systemic-sclerosis-results-from-a-pilot-study
#24
JOURNAL ARTICLE
Eleni Pagkopoulou, Stergios Soulaidopoulos, Niki Katsiki, Afroditi Malliari, Charalampos Loutradis, Asterios Karagiannis, Michael Doumas, Alexandros Garyfallos, George Kitas, Theodoros Dimitroulas
INTRODUCTION/OBJECTIVES: Systemic sclerosis (SSc) is characterized by generalized vasculopathy affecting mainly small vessels while macrovascular involvement is less investigated. The aim of this study was to examine associations between asymmetric dimethylarginine (ADMA) - a biomarker of atherosclerosis - and assessments of macrovascular endothelial function in patients with SSc. METHODS: This was a cross-sectional study including consecutive SSc patients attending the Scleroderma Outpatient Clinic...
December 19, 2022: Clinical Rheumatology
https://read.qxmd.com/read/36396789/pulmonary-hypertension-in-connective-tissue-diseases-epidemiology-pathogenesis-and-treatment
#25
REVIEW
Döndü Üsküdar Cansu, Cengiz Korkmaz
Pulmonary hypertension (PH) is a clinical condition characterized by increased pulmonary arterial pressure arising from a heterogeneous range of diseases that has a deteriorating effect on the quality of life and may cause early mortality if left untreated. Connective tissue disorders (CTD)-associated PH is the second most common cause of pulmonary arterial hypertension (PAH), after the idiopathic form, categorized as group I. Systemic scleroderma (SSc) accounts for 75% of CTD-associated PH cases. Although SSc ranks first place for CTD-associated PH, SSc is followed by systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD), having a lesser frequency of PH occurrence, while it occurs as a rare complication in cases with rheumatoid arthritis (RA) and inflammatory myositis...
October 2023: Clinical Rheumatology
https://read.qxmd.com/read/36259603/the-clinical-implications-of-left-ventricular-diastolic-dysfunction-in-systemic-sclerosis
#26
JOURNAL ARTICLE
Laura Ross, Shreeya Patel, Wendy Stevens, Andrew Burns, David Prior, Andre La Gerche, Mandana Nikpour
OBJECTIVES: We sought to quantify the burden of left ventricular diastolic dysfunction (LVDD) and heart failure with preserved ejection fraction (HFpEF) in systemic sclerosis (SSc) and assess the progression of LVDD over time and its prognostic importance. METHODS: Two-hundred and twenty-five participants enrolled in the Australian Scleroderma Cohort Study were included and LVDD was assessed according to 2016 ASE/EACVI Guidelines. Logistic regression analyses and generalised estimating equations were performed to evaluate the relationship between LVDD and SSc disease characteristics and symptoms and signs of heart failure, respectively...
October 2022: Clinical and Experimental Rheumatology
https://read.qxmd.com/read/36211199/extranodal-localization-of-non-hodgkin-s-lymphoma-in-systemic-sclerosis-a-diagnostic-challenge-and-review-of-the-literature
#27
Giorgio Galoppini, Beatrice Maranini, Giovanni Ciancio, Melissa Padovan, Gian Luca Casoni, Francesco Cavazzini, Roberta Gafà, Giovanni Lanza, Marcello Govoni
Background: Systemic sclerosis is associated with an increased incidence of malignancies, in particular solid neoplasms. Hematological cancers have been also observed in autoimmune diseases, though rarely present with lung involvement. The latter may be misdiagnosed in systemic sclerosis patients, due to the frequent concomitant interstitial lung disease. Case description: Here, we present the case of a 63-year-old man affected by systemic sclerosis presenting with an atypical lung imaging and splenomegaly, who was diagnosed with splenic marginal zone lymphoma, thus raising the suspicion of lung secondarism...
October 2022: Journal of Scleroderma and related Disorders
https://read.qxmd.com/read/36184202/oral-enteral-and-parenteral-nutritional-therapies-in-scleroderma-a-systematic-review
#28
JOURNAL ARTICLE
Niamh Keane, Amina Ghannam, Konstantinos C Fragkos, Farooq Rahman
BACKGROUND & AIMS: Scleroderma is a multi-system disease that causes hardening of connective tissue. The gastrointestinal (GI) tract is affected in 90% of patients, which may cause nutritional decline. Due to the rarity of the disease, current nutritional guidelines in scleroderma are extrapolated from evidence in other chronic diseases. This systematic review examines the effects of oral nutrition supplements (ONS), enteral nutrition (EN) and parenteral nutrition (PN) on both clinical and nutritional outcomes of scleroderma patients...
October 2022: Clinical Nutrition ESPEN
https://read.qxmd.com/read/36049974/role-of-cardiopulmonary-exercise-test-in-early-diagnosis-of-pulmonary-hypertension-in-scleroderma-patients
#29
JOURNAL ARTICLE
Paula Sánchez-Aguilera Sánchez-Paulete, María Lázaro Salvador, Alejandro Berenguel Senén, Clara Méndez Perles, Luis Rodríguez Padial
INTRODUCTION: Pulmonary arterial hypertension (PAH) is a severe, high mortality and progressive disease. Early diagnosis and treatment improves the prognosis. Patients with scleroderma disease presents high risk of developing PAH. Established screening strategies - echocardiogram and DETECT algorithm - recognize the disease when it is already advanced. Cardiopulmonary exercise testing (CPET) detects pulmonary vascular injury in earlier stages. METHODS: Prospective study of 52 consecutive patients diagnosed of scleroderma in our health area, during 2 years (2018 and 2019)...
April 6, 2023: Medicina Clínica
https://read.qxmd.com/read/35648373/renal-disease-and-systemic-sclerosis-an-update-on-scleroderma-renal-crisis
#30
REVIEW
Alice Cole, Voon H Ong, Christopher P Denton
Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc) with a mortality of 20% at 6 months. Once the leading cause of mortality in scleroderma (SSc), it remains a serious complication, often necessitating level three care for patients affected. Whilst renal outcomes have significantly improved following the advent of angiotensin-converting enzyme inhibitor (ACEi) therapy, SRC remains a precarious challenge for clinicians, due to lack of preventative measures and the fact that patients can rapidly decline despite best medical management...
June 2023: Clinical Reviews in Allergy & Immunology
https://read.qxmd.com/read/35593962/autoantibodies-and-cancer-association-the-case-of-systemic-sclerosis-and-dermatomyositis
#31
REVIEW
David F Fiorentino, Livia Casciola-Rosen
Several rheumatic diseases have a perplexing association with cancer. Unraveling this mysterious connection is likely to provide deeper understanding regarding mechanisms governing the onset of both autoimmunity and cancer immunity, in addition to providing clinicians much needed guidance around whom and when to screen for occult malignancy. Systemic sclerosis (scleroderma) and dermatomyositis are two diseases in which the association with internal malignancy is well-described and can be considered as models from which to gain important insights that likely have broader applicability...
December 2022: Clinical Reviews in Allergy & Immunology
https://read.qxmd.com/read/35386744/development-of-the-optimal-touchscreen-interface-for-patients-with-scleroderma
#32
JOURNAL ARTICLE
Gianluca Moroncini, Agnese Brunzini, Alessandra Papetti, Emanuele Filippini, Valentina Maurizi, Giulia Cesaretti, Rosaria Gesuita, Armando Gabrielli, Michele Germani
Impaired hand function is a major contributor to overall disability and reduced health-related quality of life in scleroderma patients. A relevant issue concerns interaction of scleroderma subjects with touchscreen interfaces. This study aims at investigating this problem assessing scleroderma patients' performance with a novel, aptly designed, touchscreen application in order to identify critical items of touchscreen technology which may impair or facilitate the use by scleroderma subjects. Eighty scleroderma patients performed this novel application including three games, each of which tested a different gesture: tapping, dragging/dropping, and pinching-to-zoom...
June 2021: Journal of Scleroderma and related Disorders
https://read.qxmd.com/read/35033725/dental-implants-in-patients-suffering-from-autoimmune-diseases-a-systematic-critical-review
#33
JOURNAL ARTICLE
Jane-Frances Onyinye Esimekara, Alexandre Perez, Delphine S Courvoisier, Paolo Scolozzi
PURPOSE: This systematic review aimed to evaluate complications and survival rates of dental implants placed in patients suffering from autoimmune diseases. MATERIALS AND METHODS: A systematic review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses systematic review guidelines (PRISMA), using Google scholar and PubMed electronic databases with a stop date of September 2021. The eligibility criteria included all full text human studies in the English language literature reporting on patients with autoimmune diseases treated with dental implants...
January 13, 2022: Journal of Stomatology, Oral and Maxillofacial Surgery
https://read.qxmd.com/read/34978265/validation-of-turkish-version-of-the-cochin-17-item-scleroderma-functional-scale
#34
JOURNAL ARTICLE
Nurten Gizem Tore, Deran Oskay, Aslıhan Avanoglu Guler, Abdurrahman Tufan
INTRODUCTION: The Cochin 17-item Scleroderma Functional (CSF-17) Scale is a patient-reported outcome measure evaluating activities and participation in patients with systemic sclerosis (SSc). OBJECTIVE: The aim of the present study was to translate and cross-culturally adapt the CSF-17 into the Turkish language and investigate its convergent validity and reliability in Turkish-speaking patients with SSc. METHODS: The CSF-17 was cross-culturally adapted according to Beaton's guideline...
January 2, 2022: Physiotherapy Theory and Practice
https://read.qxmd.com/read/34835261/flu-and-pneumococcal-vaccine-coverage-in-scleroderma-patients-still-need-to-be-prompted-a-systematic-review
#35
REVIEW
Francesca Rosamilia, Giovanni Noberasco, Dario Olobardi, Andrea Orsi, Giancarlo Icardi, Francesca Lantieri, Giuseppe Murdaca
Systemic sclerosis (scleroderma, SSc) is an autoimmune connective tissue disease characterized by excessive production of collagen and multiorgan involvement. Scleroderma patients are at increased risk of influenza complications and pneumonia; thus, vaccinations are recommended. This systematic review evaluated the influenza and pneumococcus vaccination coverage for SSc patients. We included all studies from Pubmed reporting on influenza and pneumococcal vaccination rate in Scleroderma patients up to May 2021...
November 15, 2021: Vaccines
https://read.qxmd.com/read/34835183/new-onset-and-relapsed-kidney-histopathology-following-covid-19-vaccination-a-systematic-review
#36
REVIEW
Henry H L Wu, Philip A Kalra, Rajkumar Chinnadurai
INTRODUCTION: The introduction of COVID-19 vaccination programs has become an integral part of the major strategy to reduce COVID-19 numbers worldwide. New-onset and relapsed kidney histopathology have been reported following COVID-19 vaccination, sparking debate on whether there are causal associations. How these vaccines achieve an immune response to COVID-19 and the mechanism that this triggers kidney pathology remains unestablished. We describe the results of a systematic review for new-onset and relapsed kidney histopathology following COVID-19 vaccination...
October 29, 2021: Vaccines
https://read.qxmd.com/read/34701588/re-evaluating-the-toxicity-of-radiotherapy-in-patients-with-collagen-vascular-disease-a-meta-analysis-of-propensity-score-studies
#37
JOURNAL ARTICLE
B L Liu, W Liu, A Leung, J Park, G Boldt, D A Palma, M I Lock
PURPOSE/OBJECTIVE(S): Collagen vascular disease (CVD) is considered a relative contra-indication to radiotherapy. We sought to determine rates of acute and late radiotherapy-associated toxicity in patients with CVD compared to matched controls. MATERIALS/METHODS: A systematic review was performed following PRISMA guidelines. PubMed was searched for articles from inception to February 2021. Search terms included collagen vascular disease and subtypes; radiotherapy; and cancer...
November 1, 2021: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/34668513/assessing-the-role-for-nailfold-videocapillaroscopy-in-interstitial-lung-disease-classification-a-systematic-review-and-meta-analysis
#38
JOURNAL ARTICLE
Eshwar Umashankar, Christina Abdel-Shaheed, Marshall Plit, Laila Girgis
OBJECTIVES: The nailfold videocapillaroscopy (NVC) has been known to assist with Interstitial Lung Disease (ILD) classification. However, evidence on its diagnostic efficacy is limited, particularly in some connective tissue disease-related interstitial lung diseases (CTD-ILD), and in interstitial pneumonia with autoimmune features (IPAF). This study aimed to address this limitation by conducting a meta-analysis on the efficacy of the NVC in ILD subgroups of CTD-ILD, IPAF and idiopathic pulmonary fibrosis (IPF)...
October 20, 2021: Rheumatology
https://read.qxmd.com/read/34418468/radiation-toxicity-in-patients-with-collagen-vascular-disease-a-meta-analysis-of-case-control-studies
#39
JOURNAL ARTICLE
Parvez M Shaikh, Sarah A Singh, Fiori Alite, John A Vargo, Bahman Emami, Meng-Jia Wu, Geraldine Jacobson, Veli Bakalov, William Small, Basem Dahshan, Joshua Weir, Paul B Renz, Matthew M Harkenrider
PURPOSE: Several retrospective series have reported that patients with collagen vascular disease (CVD) are at increased risk of radiation (RT) toxicity. However, the evidence is mixed, and many series lack control groups. We performed a meta-analysis including only case-cohort or randomized studies that examined the risk of RT toxicity for patients with CVD compared with controls. METHODS AND MATERIALS: Meta-analysis of Observational Studies in Epidemiology guidelines were used to perform a comprehensive search identifying case-control or randomized studies reporting RT toxicity outcomes for patients with CVD versus controls...
December 1, 2021: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/34414042/systemic-sclerosis-associated-interstitial-lung-disease-and-nintedanib-a-rare-disease-and-a-promising-drug
#40
REVIEW
Sunam Kafle, Manusha Thapa Magar, Priyanka Patel, Arisa Poudel, Ivan Cancarevic
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a rare disease with a progressive nature, eventually leading to lung fibrosis. Nintedanib, a tyrosine kinase inhibitor, is a widely accepted drug for treating idiopathic pulmonary fibrosis (IPF), a disease that shares some similarities with SSc-ILD regarding pathological disease processes. In this review, we aim to discuss the pathogenesis of SSc-ILD and the overall role of nintedanib in the management of SSc-ILD. SSc-ILD involves multiple pathological mediators contributing to various pathways that ultimately cause lung fibrosis...
July 2021: Curēus
keyword
keyword
119698
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.